Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Arthritis and Rheumatology is Scopus-indexed (Q1, CiteScore 19.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2326-5191Verify ISSN ↗2326-5205Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$5,190 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Rheumatology | 4 / 77 | 95th | Q1 |
| Immunology and Allergy | 14 / 234 | 94th | Q1 |
| Immunology | 15 / 243 | 94th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 19.9.
Arthritis and Rheumatology is Q1 in Rheumatology (rank 4 of 77), Q1 in Immunology and Allergy (rank 14 of 234) and Q1 in Immunology (rank 15 of 243), by CiteScore 2025.
Arthritis and Rheumatology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 19.9, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 4.061, quartile Q1, with an H-index of 373.
The publisher lists an article processing charge of about US$5,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Arthritis and Rheumatology is published by John Wiley and Sons Ltd. Its print ISSN is 2326-5191 and its online ISSN is 2326-5205.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Arthritis and Rheumatology has an h-index of 188 and a 2-year mean of 4.06 citations per paper (OpenAlex). Its Scopus CiteScore is 19.9, quartile Q1. On 2-year citations it ranks #9 of 74 Scopus journals in Rheumatology.
Arthritis and Rheumatology published 413 papers in 2025; its busiest recent year was 2020 with 426. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2026), authors are most often from United States (35.3%), China (12.6%) and France (6.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.